Professional Documents
Culture Documents
CHEM4242-DNA Revised
CHEM4242-DNA Revised
Abstract
ALDH2 encodes aldehyde dehydrogenase, which is an essential component of human ethanol
metabolism. The SNP (Single Nucleotide Polymorphism) of the human ALDH2 gene inactivates
aldehyde dehydrogenase due to the replacement of base 37,030 in the genomic sequence, and the
frequency of the mutant ALDH2 gene is particularly high in the East Asian population. Aimed at the
difference of this single base, this experiment applies PCR-Restriction fragment length polymorphism
(RFLP) to distinguish the three ALDH2 genotypes after extraction, purification, and enzymatic
digestion of the genomic DNA from human oral epithelium.
Introduction
Aldehyde dehydrogenase (ALDH) is a protein that catalyzes the oxidation of aldehydes, including
acetaldehyde [1]. The human genome has identified 19 functional ALDH genes, categorized into four
classes: ALDH1-4. Among them, the ALDH2 gene is unique due to its high expression level and
genetic polymorphism compared to the other three classes [2].
The ALDH2 gene exhibits sequence polymorphisms, with the most common mutation being
g.37030G>A. This mutation replaces the glutamate residue at position 487 of the ALDH2 amino acid
sequence with lysine, resulting in a significant loss of catalytic activity in the synthesized aldehyde
dehydrogenase. The wild-type gene encoding the normal enzyme is referred to as ALDH2*1 (G), while
the mutated gene encoding the inactivated enzyme is referred to as ALDH2*2 (A). Biochemical studies
have shown that the absence or structural alteration of any subunit in the ALDH2 tetramer is sufficient
to decrease or even abolish the enzymatic activity. Therefore, enzymes encoded by the heterozygous
Glu487/Lys487 (ALDH2*1/2) genotype do not exhibit high catalytic activity, with only approximately
10-20% of the activity observed in the homozygous wild-type (ALDH2*1/1) genotype. The lysine487
homozygous mutation (ALDH2*2/2) results in a 96% loss of enzymatic activity, rendering it virtually
incapable of ethanol oxidation metabolism. In the primary hepatocytes utilizing the ethanol metabolic
pathway II, a decrease in aldehyde dehydrogenase catalytic activity leads to the inefficient metabolism
of acetaldehyde produced after alcohol ingestion. Consequently, a large number of acetaldehyde
molecules enter the bloodstream and participate in systemic circulation. Accumulation of acetaldehyde
in facial capillaries, due to its vasodilatory effect, leads to the phenomenon commonly known as "Asian
Glow," characterized by facial flushing when consuming alcohol [3, 4].
The frequency of ALDH2 gene polymorphisms varies among different ethnicities. Compared to
European and African populations, the ALDH2*2 gene is more widely distributed in East Asian
populations, resulting in a larger proportion of individuals with impaired acetaldehyde metabolism and
a higher susceptibility to alcohol-related complications such as facial flushing. In the Chinese Han
population, the frequency of ALDH22 allele is 17-29%, while the genotype frequency of ALDH2*1/*2
heterozygotes is 36-44%, and ALDH2*2/*2 homozygotes frequency is 7-8% [5, 6], which are
relatively high levels worldwide.
PCR is a technique used to amplify specific DNA sequences in a sample. It involves repeated cycles
of DNA denaturation, primer annealing, and DNA synthesis using a heat-stable DNA polymerase. In
the case of ALDH2 mutation detection, specific primers are designed to target the region of interest in
the ALDH2 gene. If a mutation is present in the targeted region, the PCR amplification will result in a
different-sized DNA fragment compared to the wild-type allele. By analyzing the sizes of the PCR
products, we can identify the presence of ALDH2 mutations.
Enzyme restriction analysis, also known as restriction fragment length polymorphism (RFLP), utilizes
specific restriction enzymes that recognize and cut DNA at specific DNA sequences. These enzymes
are sensitive to sequence variations, including point mutations or single nucleotide polymorphisms
(SNPs). In the case of ALDH2 mutations, specific restriction enzymes, such as AcuI, are selected to
cut the DNA at or near the mutation site. If the mutation alters or creates a recognition site for the
restriction enzyme, the digestion pattern will be different between the wild-type and mutant alleles.
This difference can be visualized by gel electrophoresis, allowing for the identification of ALDH2
mutations.
Fig.2 Schematic presentation of the enzyme restriction principle
Fig.3 Fragments of different lengths from a PCR reaction are run on a gel.
2. Experimental
2.1 Materials
1) The saliva DNA extraction kit
2) The PCR reagents (2* Rapid Taq Master Mix)
3) TrackIt™ 100 bp DNA Ladder
4) Primers
5) The restriction endonuclease AcuI
6) PCR tube, 1.5mL tube, PCR rack
7) Agarose, TAE buffer, DNA gel plate
8) Disposable paper cups
2.2 Instrument
1) benchtop centrifuge
2) microplate reader
3) vortex mixer
4) PCR machine
5) metal bath
6) water bath
7) electronic balance
8) microwave oven
9) electrophoresis system
10) gel imaging system, etc.
PCR program:
1) Initial denaturation: 95.0°C for 3 min
2) Denaturation: 95.0°C for 15 s
3) Annealing: 58°C for 15 s
4) Extension: 72.0°C for 10 s
5) Additional extension: 72.0°C for 5 min
6) The cycle is repeated 35 times.
4. Questions
1) Discuss the electrophoresis results of enzyme digestion products
2) Briefly explain the mechanism of enzyme digestion
3) Discuss viable methods to increase the purification concentration of PCR amplification
products
4) Explain the mechanism of PCR amplification and application
Reference
[1] Tsou, P.-S., et al. (2011) Differential Metabolism of Organic Nitrates by Aldehyde Dehydrogenase
1a1 and 2: Substrate Selectivity, Enzyme Inactivation, and Active Cysteine Sites. The AAPS Journal,
13, 548-555.
[2] Yoval-Sánchez, B. and Rodríguez-Zavala, J.S. (2012) Differences in Susceptibility to Inactivation
of Human Aldehyde Dehydrogenases by Lipid Peroxidation Byproducts. Chemical Research in
Toxicology, 25, 722-729.
[3] Gross, E.R. et al. (2015) A Personalized Medicine Approach for Asian Americans with the
Aldehyde Dehydrogenase 2*2 Variant. Annual Review of Pharmacology and Toxicology, 55, 107-127.
[4] Wang, W.J., Wang, C.G., Xu, H.X. and Gao, Y.H. (2020) Aldehyde Dehydrogenase, Liver Disease
and Cancer. International Journal of Biological Sciences, 16, 921-934.
[5] Zhang, L.-Q., et al. (2017) Association of Genotypes of rs671 withinALDH2 with Risk for Gastric
Cardia Adenocarcinoma in the Chinese Han Population in High- and Low-Incidence Areas. Cancer
Biology & Medicine, 14, 60-65.
[6] Xia, J.-Q., et al. (2015) Effect of Aldehyde Dehydrogenase 2 Gene Polymorphism on
Hemodynamics after Nitroglycerin Intervention in Northern Chinese Han population. Chinese Medical
Journal, 128, 180-185.